The headline numbers for Albemarle (ALB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Albemarle (ALB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.83 per share. This compares to earnings of $0.04 per share a year ago.
Lithium has likely bottomed after a brutal selloff, with supply cuts and project halts setting the stage for a multi-year recovery. Albemarle is financially resilient, has cut costs, and trades near book value, offering a compelling risk/reward for contrarian investors. Supply/demand dynamics are improving, and lithium demand remains a secular trend, though macroeconomic and regulatory risks persist.
![]() ALB In 1 month Announced | Quarterly | $0.41 Per Share |
![]() ALB 1 month ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 4 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 7 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 10 months ago Paid | Quarterly | $0.41 Per Share |
29 Oct 2025 (In 3 months) Date | | - Cons. EPS | - EPS |
30 Jul 2025 Date | | - Cons. EPS | - EPS |
30 Apr 2025 Date | | - Cons. EPS | - EPS |
12 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
![]() ALB In 1 month Announced | Quarterly | $0.41 Per Share |
![]() ALB 1 month ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 4 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 7 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 10 months ago Paid | Quarterly | $0.41 Per Share |
29 Oct 2025 (In 3 months) Date | | - Cons. EPS | - EPS |
30 Jul 2025 Date | | - Cons. EPS | - EPS |
30 Apr 2025 Date | | - Cons. EPS | - EPS |
12 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
Chemicals - Specialty Industry | Basic Materials Sector | Jerry Kent Masters Jr. CEO | XWBO Exchange | US0126531013 ISIN |
US Country | 8,300 Employees | 14 Mar 2025 Last Dividend | 2 Mar 2007 Last Split | 17 Feb 1994 IPO Date |
Albemarle Corporation is centered around the development, manufacturing, and marketing of specialty chemicals on a global scale. The company's operations are segmented into Energy Storage, Specialties, and Ketjen, catering to a wide array of industries including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Founded in 1887 and with its headquarters in Charlotte, North Carolina, Albemarle has established itself as a key player in the engineered specialty chemicals market.
This segment delivers lithium compounds like lithium carbonate, lithium hydroxide, and lithium chloride. It also provides technical services for the safe handling and usage of reactive lithium products, in addition to recycling services for lithium-containing by-products. These offerings play a crucial role in supporting the demanding energy storage market.
In this segment, Albemarle offers bromine-based specialty chemicals, including elemental bromine, various bromides, brominated powdered activated carbon, and other fine chemicals. It also features lithium specialties such as butyllithium and lithium aluminum hydride, and develops and manufactures cesium products for chemical and pharmaceutical applications. Furthermore, this segment provides zirconium, barium, and titanium products designed for use in pyrotechnical applications including airbag initiators, serving diverse markets from construction to pharmaceuticals.
Focused on clean fuels technologies (CFT), the Ketjen segment encompasses hydroprocessing catalysts (HPC) along with isomerization and akylation catalysts. It also provides fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS) which include organometallics and curatives. These products and technologies are vital for the petroleum refining industry, ensuring more efficient processing and higher-quality fuel production.